Vasculonics
Vasculonics is a preclinical stage biotechnology company focused on developing new class of disease modifying medicine for pulmonary artery hypertension (PAH) and chronic kidney disease (CKD).
7-day free trial · no credit card
Verified contacts
4
available on Kipplo
LinkedIn employees
3
1 to 10 range
Open roles
—
no listings
Distinct roles
3
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 4 verified contacts at Vasculonics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
4 contacts with verified email or phone · masked until revealed.
- BL
Brad Lawson
Board Member and Interim CEO · General Business & Management
EmailPhone - YL
Young Lee
Project Leader · Research & Development
EmailPhone - BL
Brad Lawson
Board Member and Interim CEO · General Business & Management
EmailPhone
Showing 3 of 4 verified contacts
Top roles at Vasculonics
3 distinct titles indexed · top 3 shown.
- 2board member and interim ceo
- 1founder and chief scientific officer
- 1project leader
Sign up to unlock all 4 contacts at Vasculonics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 4 verified contacts at Vasculonics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.